At our core, we’ve always been focused on innovation in healthcare services, leveraging technology to enhance how providers deliver care. From electronic health records (EHR) and smart systems to algorithms and Artificial Intelligence (AI), our goal has always been to empower consumers and advance scientific progress. Along the way, we’ve designed over 30 patents, many of which touch on the potential of using crypto tokens. For years, our ideas were dismissed as too ambitious or disruptive—some even labeled crypto as “toxic.” But we saw a future where this technology would play a crucial role in healthcare, and though good innovations may face delays, they are rarely truly squashed.
In past blogs, we’ve discussed how, under President Trump, executive orders would help the U.S. emerge from a dark winter of crypto scams and harsh actions from the U.S. Securities and Exchange Commission (SEC) against cryptocurrency projects. That future is now arriving, and we’re excited about the opportunity to contribute to the next wave of innovation. Crypto has long been polarized—on one hand, there are “meme tokens” viewed mainly as collectibles, and on the other, more serious innovations like stablecoins.
Let’s take a moment to clarify stablecoins: These are cryptocurrencies pegged to a reserve asset, like the U.S. dollar, euro, or commodities. They aim to provide the borderless transaction benefits of digital assets while offering the price stability of traditional currencies.
While stablecoins are an interesting way to store dollars and can be easily transferred, I see traditional U.S. brokers or banks as more reliable for holding actual dollars. Stablecoins can be useful for certain applications, like paying interest similar to a money market fund, but I don’t view them as a means for true capital formation. They seem more like a management tool for those managing assets, such as a money market fund or exchange-traded fund (ETF), earning management fees.
The Big News: Senate Hearing on March 27, 2025
At a Senate Banking Committee hearing on March 27, 2025, Paul Atkins—President Donald Trump’s nominee for SEC Chair—expressed his strong support for creating a rational, innovation-friendly framework for digital assets. This marked a clear departure from the previous administration’s more enforcement-heavy approach. Atkins emphasized that cryptocurrency and blockchain technologies represent an “unprecedented opportunity” to modernize financial infrastructure and unlock new forms of capital formation, especially for startups, emerging companies, and decentralized finance (DeFi) platforms.
His testimony was welcomed by industry advocates who have long called for regulatory clarity. They believe clearer guidelines will allow legitimate projects to thrive without the looming threat of enforcement actions.
Innovation-Driven Policy
Atkins made it clear that the SEC should not hinder technological progress in crypto, blockchain, and tokenization with outdated frameworks meant for traditional securities. Instead, the SEC must develop a “modern playbook” that accounts for the unique structures of digital assets, such as utility tokens, stablecoins, and decentralized protocols.
This approach mirrors a growing sentiment in Washington that the U.S. risks falling behind global competitors—countries like the U.K., Singapore, and the UAE, which have developed comprehensive digital asset regulations. These jurisdictions encourage innovation while mitigating risks.
Capital Formation in the Crypto Economy
A key theme in Atkins’ testimony was the potential of crypto and blockchain-based financial products to foster capital formation. Blockchain technology can reduce friction in capital markets, lower transaction costs, and enhance transparency through smart contracts and immutability.
Atkins pointed to examples like tokenized equity offerings, digital asset funds, and on-chain debt instruments as financial products that could open up broader participation in capital markets, especially for underserved sectors. If regulated with clarity, these products could drive more participation from both issuers and investors. He also called for collaboration with other regulators and Congress to create a unified regulatory environment that allows for responsible experimentation.
Toward Principles-Based Regulation
Atkins wrapped up his testimony by advocating for principles-based regulation over prescriptive rulemaking. He emphasized, “We should encourage compliance through clarity, not confusion,” highlighting the need for clearer definitions and streamlined registration processes for crypto projects.
His remarks suggested a more collaborative SEC approach, one that listens to innovators and stakeholders. This is a significant shift from the adversarial stance seen in recent years.
Industry Reaction and Outlook
The crypto and fintech communities have largely reacted positively to Atkins’ testimony, viewing it as a turning point for U.S. regulatory policy. If confirmed, Atkins is expected to lead a regulatory strategy that positions digital assets as transformative tools for economic inclusion, innovation, and capital formation.
Under his leadership, the SEC could provide the clarity and confidence needed to spark a new wave of innovation in blockchain and crypto finance, helping the U.S. reclaim its leadership in financial technology.
Our View
For us, this is truly exciting news. We’ve long advocated for and even patented the use of crypto tokens in healthcare. Our work, particularly in exchanging valuable data, stands to benefit greatly from the new regulatory environment Atkins envisions. We are ready to bring value to consumers, advance science, and reward investors in this new era of innovation.
About HealthScoreAI ™
Healthcare is at a tipping point, and HealthScoreAI is positioning to revolutionize the industry by giving consumers control over their health data and unlocking its immense value. U.S. healthcare annual spending has exceeded $5 trillion with little improvement in outcomes. Despite advances, technology has failed to reduce costs or improve care. Meanwhile, 3,000 exabytes of consumer health data remain trapped in fragmented USA systems of 500 EHRs, leaving consumers and doctors without a complete picture of care.
HealthScoreAI seeks to provide a unique solution, acting as a data surrogate for consumers and offering an unbiased holistic view of their health. Giving Consumers tools to respond to denial of care by insurers, we aim to bridge gaps in healthcare access and outcomes. By monetizing de-identified data, HealthScoreAI seeks to share revenue with consumers, potentially creating a new $100 billion market value opportunity. With near-universal EHR adoption in the USA, and advances in technology, now is the perfect time to capitalize on the data available, practical use of AI and the empowering of consumers, in particular the 13,000 tech savvy baby boomers turning 65 every single day and entering the Medicare system for the first time. Our team, with deep healthcare and tech expertise, holds U.S. patents and a proven track record of scaling companies and leading them to IPO.
Noel J. Guillama-Alvarez
https://www.linkedin.com/in/nguillama/
+1-561-904-9477, Ext 355
https://www.reuters.com/world/us/trumps-sec-pick-pledges-rational-crypto-regulations-2025-03-26/
https://oxiohealth.io/breaking-news-2-0-sec-shifts-stance-on-crypto/
https://oxiohealth.io/healthcare-ai-crypto-and-president-trump-47/
https://oxiohealth.io/healthcare-ai-crypto-president-trump-47-episode-i/